We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00795990
First Posted: November 24, 2008
Last Update Posted: December 5, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Utah
November 20, 2008
November 24, 2008
December 5, 2014
November 2008
November 2014   (Final data collection date for primary outcome measure)
Early versus Late Medical Treatment of PDA [ Time Frame: 1 month ]
The primary objective is to compare early (day of life 4 or less) versus late (day of life 5) medical treatment of PDA. Data will be collected via a retrospective chart review. Information will be collected on both the use of indomethacin and ibuprofen. Both medications are used as standard of care in the NICU for closure of PDAs.
Not Provided
Complete list of historical versions of study NCT00795990 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008. The purpose is to compare the outcomes of medical intervention in preterm infants if intervention occurs day of life 4 or less, or day of life 5 or greater, with the birthdate being counted as day of life 1.
This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008. The purpose is to compare the outcomes of medical intervention in preterm infants if intervention occurs day of life 4 or less, or day of life 5 or greater, with the birthdate being counted as day of life 1. All infants born less than 1200 gms will be evaluated for whether or not an echocardiogram was done. If an echocardiogram was done that showed a PDA, data will be collected as to what medical interventions were done, at what age, and what were the results of the medical intervention. Infants will be stratified into birthweights <800 gm and 800-1200 gm.
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Premature infants born weighing less than 1200 gms with echo confirmed PDA
Patent Ductus Arteriosus
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
350
November 2014
November 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • birth weight less than 1200 gm

Exclusion Criteria:

Sexes Eligible for Study: All
up to 3 Months   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00795990
31769
No
Not Provided
Not Provided
Carrie Rau, University of Utah
University of Utah
Not Provided
Principal Investigator: Gary M Chan, MD University of Utah
University of Utah
December 2014